Author Archives: Pharm Exec

Pharma Rep Access Down 33 Per Cent Since 2008

The steady decline of pharmaceutical sales representative access to physicians is spreading to previously rep-friendly specialties, says the ZS Associates spring 2014 AccessMonitorT report.
Posted in E-Media, Marketing, multimedia, Sales, social media, Technology | Tagged , , | Leave a comment

Shire Takeover "Could Save AbbVie $8 Billion Tax on Humira over Next 15 Years"

AbbVie’s recent $54 billion acquisition of Shire and subsequent relocation to Ireland will mean substantial tax savings for the US pharmaceutical giant, according to analysts at research and consulting firm GlobalData.
Posted in Deals, Europe, Global, Strategy | Tagged , , , , | Leave a comment

Biotech Stocks Shaken by Fed Warning

Today’s Financial Times (FT) reports that nearly $40bn was wiped from the biotech market’s value last week (a 6 per cent drop in the Nasdaq biotechnology index) following the Federal Reserve’s identification of biotech shares as a cause for concern. There was some recovery on Friday however when prices rebounded 3 per cent. The US […]
Posted in Biotech | Tagged , , | Leave a comment

Pharma Online Advertising is Working

Pharmaceutical online advertising has the highest viewability rates of any industry, according to a study by comScore, Inc. Survey data from the eighth annual Online Marketing Effectiveness Benchmarks for the Pharmaceutical Industry also shows that online direct-to-consumer (DTC) marketing continues to increase conversion among patients and prospects. According to the study, which included 163 pharmaceutical […]
Posted in E-Media, multimedia, social media | Tagged , , , , | Leave a comment

EMA Delays Adoption of Policy on Publishing Trial Data

The European Medicines Agency (EMA) has postponed formal adoption of the policy on publication of clinical trial data. An EMA press statement said that “[f]urther clarifications on wording and practical arrangements will be discussed by Board members”, whose additional contributions will now be considered with a view to reaching final agreement at the Management Board meeting on 2 October. […]
Posted in Europe, Global, R&D, Regulatory | Tagged , | Leave a comment
  • Categories

  • Meta